All Episodes
Lung Cancer Considered — 416 episodes · page 1 of 5
LCC in Hebrew: WCLC 2026 Highlights
WCLC 2026 Early Career Takeover: Research, Networking, and Career Growth
LCC in Arabic: Joint IASLC/EMRO Workshop Highlights From WCLC 2026
LCC in Korean WCLC 2026 Highlights
WCLC 2026 Patient Advocate Takeover: Centering Patient Voices in Research and Care
WCLC 2026 East-West Academic Exchange: Collaborating on the Future of Lung Cancer Care
WCLC 2026 Nurse Practitioner Takeover: What APPs are Taking Back to the Clinic
LCC in Czech: WCLC 2026 Highlights
LCC in Spanish: WCLC 2026 Highlights
LCC in Portuguese: WCLC 2026 Highlights
Live From WCLC 2026: Tuesday Highlights & Meeting Summary
LCC in Mandarin: WCLC 2026 Highlights
Live From WCLC 2026: Monday Highlights
Live From WCLC 2026: Sunday Highlights
Before You Go: A Practical Guide to WCLC 2026 in Seoul
Beyond Stage IV: Rethinking Oligometastatic Lung Cancer
LCC in Korean: The Role of Immunotherapy in Lung Cancer
The Global Fight Against Lung Cancer: A Conversation with WHO's José Luis Castro
LCC: Grace Under Pressure: Navigating Burnout and Loss in Oncology
LCC Advances in ALK+ Cancer in Cantonese
Treating Advanced Thymic Cancers
FDA Approval: Zidesamtinib and ROS1 NSCLC
Rewriting the Playbook: Cellular Therapy and Vaccines for ALK-Positive Lung Cancer
IASLC - Your First Faculty Job
Game Changers & Hard Truths: Dr. Balazs Halmos Unfiltered
Welcome to Seoul: 2026 World Conference on Lung Cancer (WCLC) Preview
ASCO 2026 Highlights – Part 2: Emerging Immunotherapy Strategies in Lung Cancer
ASCO 2026 Highlights – Part 1: Landmark Advances in Targeted Therapy
Patients, AI, and Lung Cancer: Finding Clarity in the Noise
LCC in Italian: Resectable EGFR-mutant NSCLC
LCC Beyond Stage IV: Rethinking Oligometastatic Lung Cancer
AACR 2026 Highlights: KRAS Updates
LCC in Spanish: Manejo perioperatorio en cáncer de pulmón en estadio temprano
IASLC - Nursing & Allied Health in Lung Cancer Care and Clinical Research
IASLC - Lung Cancer Considered India
LCC in Korean: A Case-Based Discussion on EGFR-Mutant NSCLC
IASLC LCC - Early Stage and Preoperative Care for NSCLC and EFGR in Mandarin
IASLC - TTLC_Molecular Tumor Board
Live from TTLC 2026: ADCs Controversies
LCC in French_Virtual Tumor Board - EFGR NSCLC (1)
Virtual Tumor Board: EGFR-mutant NSCLC
Controversies in the Management of Lung Cancer: Comorbidities
• Live from TTLC 2026: Emerging Molecular Targets in Non-Small Cell Lung Cancer (NSCLC)
Virtual Tumor Board: Current Treatment for Small Cell Lung Cancer (SCLC)
IASLC Global Policy Update
• LCC in Cantonese: Updates in Surgical Approaches and Techniques in Early-Stage Lung Cancer
What do I need to know about AI? Discussing the Role of AI in Thoracic Oncology
Lung Cancer Considered: Lung Cancer Care in Areas of Conflict and War
LCC in Turkish: Virtual Tumor Board Immunotherapy for NSCLC
Lung Cancer Considered: IASLC Hot Topic in Basic & Translational Science Meeting Highlights
Lung Cancer Considered in Portuguese: Junior Faculty Perspective
Lung Cancer Considered: Role of General Media in Lung Cancer Research
Lung Cancer Considered -- Immunotherapy Toxicity: Myths & Pearls
Lung Cancer Considered: A New Shot at Progress: Amivantamab Goes SubQ
Lung Cancer Considered at the ASCO IASLC 2025 North American Conference on Lung Cancer
Lung Cancer Care in New Zealand
LCC in Spanish: Mujeres and oncologia toracica – Latinoamerica
IASLC Lung Cancer Considered: ADCs in EGFR Mutant NSCLC
Can I Take That? Integrative Medicine and Lung Cancer
LCC in Spanish: ¿Pulmón Vital: donde la ciencia se encuentra con la medicina tradicional
LCC in Georgian: WCLC 2025 Highlights
The New Face of Lung Cancer: A Conversation with Two Young Lung Cancer Warriors
LCC in Hungarian: WCLC 2025 Highlights
IASLC Lung Cancer Considered: ESMO 2025 Highlights
Lung Cancer Considered: • Rising Above: The Lung Cancer Hope Summit
LCC in Greek: WCLC 2025 Highlights
FDA Approval: Maintenance Lurbinectedin for SCLC
LCC in Arabic: WCLC 2025 Highlights
Lung Cancer Considered in Dutch: Targeting EGFR NSCLC
Lung Cancer Considered: Targeting EGFR NSCLC
Lung Cancer Considered in Japanese---2025 WCLC Highlights
LCC in Korean: WCLC 2025 Highlights
IASLC Lung Cancer Considered: FDA Approval: Subcutaneous Immunotherapy
LCC in Mandarin: WCLC 2025 Highlights with Experts from Taiwan
LCC in Portuguese: WCLC 2025 Highlights
LCC in Spanish: WCLC 2025 Through a Junior Faculty Lens
LCC in Hebrew: WCLC 2025 Highlights
Live From WCLC 2025: Tuesday Highlights & Meeting Summary
LCC in Spanish: WCLC 2025 Highlights
Live From WCLC 2025: Monday Highlights
LCC in Mandarin: WCLC 2025 Highlights
Live From WCLC 2025: Sunday Highlights
"I'm in Barcelona, Now What?" — Tips for First-Time WCLC Attendees
LCC in Mandarin: Neoadjuvant and Perioperative Therapy for Locally Advanced NSCLC
IASLC - ALK Positive Summit
LCC in Greek: Virtual Tumor Board - ALK NSCLC
Lung Cancer Considered--STK11 and KEAP1 as resistance mechanisms to immunotherapy
LCC in Cantonese: Novel Treatment for Advanced EGFR Mutant Lung Cancer
FDA Approval: Zongertinib for HER2 Mutant NSCLC
LCC in Arabic: Arab Women's Voices in Thoracic Oncology
Artificial Intelligence (AI) and Lung Cancer Treatment Decisions
Artificial Intelligence (AI) and Lung Cancer Treatment Decisions
LCC in Romanian: Management of Unresectable, EGFR-mutated Stage III Lung Cancer in Romania
IASLC - Stigma
LCC in Japanese: ASCO 2025 Highlights
Preview: IASLC | ASCO 2025 North American Conference on Lung Cancer
FDA Approval: Datopotamab Deruxtecan for EGFR NSCLC
FDA Approval: Sunvozertinib for EGFR Exon 20
LCC in Portuguese: Virtual Tumor Board - EGFR NSCLC
IASLC_WCLC 2025 Preview